According to the report "Liquid Biopsy Market", published by Market Data Forecast, the global market is projected to reach USD 1.75 Billion by 2021, at a CAGR of 24.3% from 2016 to 2021.
Widespread acceptance of liquid biopsy technique in North America and steady adoption in developing regions is expected to drive global liquid biopsy market revenues. The global market is expected to reach US$ 407 Mn in 2016, up from US$ 351 Mn in 2015. North America will continue to remain the largest market for liquid biopsy, accounting for over 50% share of the global market.
Biopsy involves extracting a sample of tissue and testing it for the presence of diseases especially cancer. Traditional tissue biopsy is a painful technique and also has a high rate of false results. Moreover the technique is costly, time consuming and not applicable for extracting samples such as those close to vital organs such as heart. Liquid biopsy overcomes these problems of tissue biopsy by using biomarkers present in samples such as blood, ... Read more
This report on the global liquid biopsy market analyzes the current and future prospects of the market. The report comprises a comprehensive executive summary, including a market snapshot that provides overall information of various segments. The research is a combination of primary and secondary research. Primary research formed the bulk of ... Read more
According to the new market research "Liquid Biopsy Market by Cancer Type (Lung, Breast, Colorectal, Prostate), Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA, Cell-Free DNA), Product (Instruments, Assay Kits), End User (Reference Laboratory) - Global Forecast to 2022", The liquid biopsy market is expected to reach USD 2, ... Read more
According to research report the global liquid biopsy market is projected to reach USD 2,047.9 million by 2022 from USD 715.7 million in 2017, at a CAGR of 23.4%. The factors driving the growth of this market are the increasing prevalence of cancer, increasing preference for noninvasive procedures, initiatives undertaken by government and global health organizations, technological advancement to ... Read more
Liquid biopsy overcomes these problems of tissue biopsy by using biomarkers present in samples such as blood, urine etc. and thus is a comparatively non-invasive technique. Liquid biopsy also provides greater information about the sample which is real time. The real time data can be used for monitoring and thereby determining the treatment for diseases such as cancer. The greater sensitivity of tissue biopsy coupled with the development of ... Read more
Liquid biopsy overcomes these problems of tissue biopsy by using biomarkers present in samples such as blood, urine etc. and thus is a comparatively non-invasive technique. Liquid biopsy also provides greater information about the sample which is real time. The real time data can be used for monitoring and thereby determining the treatment for diseases such as cancer. The greater sensitivity of tissue biopsy coupled with the development of sophisticated detectors with extremely low detection ... Read more
TMR predicts that the global liquid biopsy market, which was estimated to be worth US$3,883.2 mn, is projected to reach US$9071.7 mn by 2026. The global liquid biopsy market, thus, is anticipated to rise at 10.1% CAGR over the forecast period 2018 to 2026.
North America and Europe held dominant shares in the global liquid biopsy market in 2017. The ... Read more
The key factors driving the growth of this market include increasing prevalence of cancer, increasing preference for non-invasive procedures, initiatives undertaken by government and global health organizations, technological advancement to augment market revenues, rising emphasis on personalized medicine, and availability of funding for liquid biopsy R&D.
According to the new market research Liquid Biopsy Market is expected to reach USD 2,047.9 Million by 2022 from an estimated ... Read more
Liquid biopsy overcomes these problems of tissue biopsy by using biomarkers present in samples such as blood, urine etc. and thus is a comparatively non-invasive technique. Liquid biopsy also provides greater information about the sample which is real time. The real time data can be used for monitoring and thereby determining the treatment for diseases such as cancer. The greater sensitivity of tissue biopsy coupled with the development of ... Read more
Transparency Market Research has published a newest report that gives out in-detail information about the working dynamics of the global liquid biopsy market. According to the research analysts, the global liquid biopsy market will exhibit a healthy double digit CAGR of 10.1% during the mentioned projection period of 2018 to 2026. With this strong growth rate, the market is expected to touch a mark of US$9071. ... Read more
Liquid biopsy overcomes these problems of tissue biopsy by using biomarkers present in samples such as blood, urine etc. and thus is a comparatively non-invasive technique. Liquid biopsy also provides greater information about the sample which is real time. The real time data can be used for monitoring and thereby determining the treatment for diseases such as cancer. The greater sensitivity of tissue biopsy coupled with the development of ... Read more
According to the recent study the liquid biopsy market is projected to reach an estimated $10.4 billion by 2027 from $4.0 billion in 2021, at a CAGR of 17% from 2021 to 2027. Growth in this market is primarily driven by increasing prevalence of cancer, preference for non-invasive procedures, and increasing need of early detection of high precision diseases in real time.
The Liquid Biopsy Market is estimated to be valued at Us$ 13,220 Mn in 2022 and is expected to exhibit a CAGR Of 4.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Liquid biopsy is a non-invasive blood test for detecting various types of cancer in the body. It allows doctors to obtain sample of tumor DNA circulating in the ... Read more
Market Overview:
A liquid biopsy is a non-invasive blood test used to screen for cancer. It analyses blood samples and detects tiny fragments of DNA released by tumor cells into the bloodstream and helps determine the presence of cancer. Liquid biopsies are useful in monitoring disease recurrence and treatment response as it can detect genetic mutations that help personalize cancer therapy.
Liquid biopsy allows the detection of various cancer types through a simple blood draw. It identifies and evaluates fragments of DNA released by tumor cells into the bloodstream. These DNA fragments provide insights about any genetic mutations occurring in the tumor. Liquid biopsy provides a simple and non-invasive alternative to surgical tumor biopsies. It assists physicians in screening, diagnosing, and monitoring cancer without requiring invasive procedures.
Liquid biopsy tests involve the sampling and analysis of blood or other body fluids for detecting and monitoring cancer. They offer minimally invasive alternatives to tissue biopsies for detecting various cancers. Advancements in liquid biopsy technologies have enabled the detection of minimal residual disease and monitoring of treatment responses. Next generation sequencing and digital PCR techniques are being applied to analyze cell-free DNA or circulating tumor cells in blood samples. ... Read more
